Thursday, October 20, 2011: 2:00 PM-5:00 PM
Chair:
Discussant:
21.2
Cardiometabolic Consequences of Antipsychotic Treatment: Final Results of the NIMH-Funded Metabolic Effects of Antipsychotics in Children (MEAC) Study
21.3
Clinical Predictors of Cardiometabolic Risk in MEAC Participants During Initial Antipsychotic Exposure
21.4
Cardiometabolic Effects of Antipsychotic Switching in Youth: Results From the SATIETY Study
21.1
Topiramate for Weight Gain in Bipolar Youth Treated with Atypical Antipsychotics
See more of: Symposium